Colchicine may be considered for the secondary prevention of cardiovascular disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Colchicine may be considered for the secondary prevention of cardiovascular disease

Published:2023-03-27 Issue:5 Volume:39 Page:167-170
ISSN:1172-0360
Container-title:Drugs & Therapy Perspectives
language:en
Short-container-title:Drugs Ther Perspect

Author:

Kim Esther S.,Lee Arnold^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40267-023-00990-6.pdf

Reference21 articles.

1. World Health Organization. Cardiovascular diseases (CVDs). 2021. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 10 Feb 2023.

2. National Heart Lung and Blood Institute. Know the difference: cardiovascular disease, heart disease, coronary heart disease. 2021. https://www.nhlbi.nih.gov/resources/know-differences-cardiovascular-disease-heart-disease-coronary-heart-disease. Accessed 10 Feb 2023.

3. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337.

4. Zhang FS, He QZ, Qin CH, et al. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. Acta Pharmacol Sin. 2022;43(9):2173–90.

5. UK National Health Service. About colchicine. 2022. https://www.nhs.uk/medicines/colchicine/about-colchicine/. Accessed 12 Feb 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP